English
Chinese
French
Arabic
Spanish
Showcasing at CPHI China, the World's Leading Pharmaceutical Ingredient Exhibition, CHU PHARMA Expands its Market in the Middle East
The 21st CPHI China Shanghai exhibition was successfully held. CHU PHARMA focused on the Middle East's essential pharmaceutical market, highlighting its sterile injectable APIs and oral formulation contract···
CHU PHARMA and Shaanxi University of Science and Technology Reach Strategic Industry-University-Research Cooperation to Jointly Establish API Process Optimization Laboratory
CHU PHARMA and Shaanxi University of Science and Technology officially signed a long-term industry-university-research cooperation agreement. Leveraging the university's mature R&D capabilities in fine ···
CHU PHARMA Officially Registered, Focusing on Core Sectors of API Export and Pharmaceutical CDMO
Recently, CHU PHARMA officially completed its business registration in Xi'an. The company focuses on "high-quality API export, customized CDMO API manufacturing, and injectable OEM production," ba···